Bibliography
- COGHLAN MJ, CARROLL WA, GOPALAKRISHNAN M: Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. j Med. Chem. (2001) 44:1627–1653.
- •This review deals with the KATp channel subtypes, their modulators and their therapeutic perspectives.
- AYABE I, TSUTSUMI O, SAKAI H et al: Increased circulating levels of insulin-like growth factor-I and decreased circulating levels of insulin-like growth factor binding protein-1 in postmenopausal women endometrial cancer. Endocrinology (1997) 44:419–424.
- STOLL BA: Breast cancer: further metabolic-endocrine risk markers? Br Cancer (1997) 76: 1652-1654.
- HANKINSON SE, WILLETT WC, COLDITZ GA et al: Circulating concentrations of insulin-like growth Factor I and risk of breast cancer. Lancet (1998) 351:1393–1396.
- TONIOLO E BRUNING PE AKHMEDKHANOV A et al: Serum insulin-like growth factor-I and risk of breast cancer. Int. j Cancer: (2000) 88:828–832.
- FRIEDEL HA, BROGDEN RN: Pinacidil.A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. Drugs (1990) 39:929–967.
- SUZUKI S, YANO K, KUSANO S, HASHIMOTO T: Antihypertensive effect of levcromakalim in patients with essential hypertension. Study by 24-h ambulatory blood pressure monitoring, Arzneimittel Forsch. (1995) 45:859–864.
- GOODE PN, FARNDON JR, ANDERSON J et al.: Diazoxide in the management of patients with insulinoma. World J. Surgery(1986) 10:586–592.
- NO AUTHORS LISTED: Diazoxide: a review of its pharmacological properties and therapeutic use in hypertensive crises. Drugs (1971) 2:78–137.
- LEBRUN EANTOINE MH, OUEDRAOGO R etal.: Activation of ATP-dependent K± channels and inhibition of insulin release: effect of BPDZ 62. Pharm. Esp. Ther. (1996) 277:156–162.
- ARGILES JM, LOPEZ-SORIANO FJ : Insulin and cancer. Int. j Oricol (2001) 4:683–687.
- ••An excellent review of the involvement ofinsulin in cancer from a multidisciplinary point of view.
- PELAIA G, GALLELLI L, VATRELLA A et al: Potential role of potassium channel openers in the treatment of asthma and chronic obstructive pulmonary disease. Life Sci. (2002) 54:977–990.
- SZEWCZYK A, WOJTCZAK L: Mitochondria as a pharmacological target. Pharmacol Rev. (2002) 54:101–127.
- OZCAN C, BIENENGRABER M, PETRAS P et al.: Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. Am. J. Physiol (2002) 282:H531–H539.
- PIROTTE B, OUEDRAOGO R, DE TULLIO P etal.: 3-Alkylamino-4H-pyrido l2, 3-el -1 2, 4-thiadiazine 1,1-dioxides structurally related to diazoxide and pinacidil as potassium channel openers acting on vascular smooth muscle cells: design, synthesis and pharmacological evaluation. j Med. Chem. (2000) 43:1456–1466.
- KOSTRZEWASKA A, LAUDANSKI T, BATRA S: Inhibition of contractile responses of human myometrium and intramyometrial arteries by potassium channel openers. Acta Obstet. Cyn. Scan. (1996) 75:886–891.